The Know AML website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and Know AML cannot guarantee the accuracy of translated content. Know AML and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

About Us

What challenges do patients with acute myeloid leukemia in complete remission face?

Norbert Vey

March 31, 2021

During the 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), Know AML spoke to Norbert Vey, Institut Paoli-Calmettes, Marseille, FR. We asked, What are some of the challenges faced by patients with acute myeloid leukemia in complete remission? Complete remission is achieved after initial chemotherapy when patients have no clinical signs of the disease, normal blood cell counts, and less than 5% leukemic blasts in their bone marrow. In this video, Vey discusses three relapse prevention methods: post-remission consolidation therapy, allogeneic transplantation, and maintenance treatment.